Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Greipp

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321Bart Barlogie, Robert A Kyle, Kenneth C Anderson, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Blood|June 14, 2003
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myelomaRafael Fonseca, Carina S Debes-Marun, Elisa B Picken, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurementsShaji Kumar, Angela Dispenzieri, Martha Q Lacy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321Bart Barlogie, Robert A Kyle, Kenneth C Anderson, et al.
Mayo Clinic Proceedings|June 1, 2010
Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapiePrashant Kapoor, Rafael Fonseca, S Vincent Rajkumar, et al.
Annals of Hematology|July 21, 2010
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureSergio Siragusa, William Morice, Morie A Gertz, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Blood|June 14, 2003
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myelomaRafael Fonseca, Carina S Debes-Marun, Elisa B Picken, et al.
Blood|November 9, 2011
Immunoglobulin D amyloidosis: a distinct entityMorie A Gertz, Francis K Buadi, Suzanne R Hayman, et al.
American Journal of Hematology|May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of boneRahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Pageof 12